Principal Investigator-Felipe Chicani, MD, Sao Paolo, Brazil
This patient comparison study will evaluate WS patients who have been treated with idebenone compared to an untreated control group to determine if idebenone can help slow the progression of WS symptoms, with a focus on vision loss.
This project is currently in the planning stage and will last a minimum of 12-24 months
Data from the past several years, current data, and data going forward will be evaluated.
http://thesnowfoundation.org/wp-content/uploads/2019/06/snow-foundation_logo.svg00The Snow Foundationhttp://thesnowfoundation.org/wp-content/uploads/2019/06/snow-foundation_logo.svgThe Snow Foundation2026-02-19 19:29:102026-02-19 19:31:06Clinical evaluation of Idebenone as a Potential Treatment for Wolfram Syndrome